OptimizeRx Corp reports results for the quarter ended December 31 - Earnings Summary

• OptimizeRx Corp OPRX.OQ reported quarterly adjusted earnings of 51 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of 30 cents. The mean expectation of seven analysts for the quarter was for earnings of 23 cents per share. Wall Street expected results to range from 19 cents to 25 cents per share.

• Revenue fell 0.2% to $32.24 million from a year ago; analysts expected $31.10 million.

• OptimizeRx Corp's reported EPS for the quarter was 26 cents​.

• The company reported quarterly net income of $5.02 million.

• OptimizeRx Corp shares had fallen by 35.8% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the online services peer group is also "buy"

• Wall Street's median 12-month price target for OptimizeRx Corp is $24.00, about 67.2% above its last closing price of $7.87

This summary was machine generated from LSEG data March 5 at 10:02 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)